Fierce Names Butterfly Network as a Fierce 50 Honoree of 2024
Butterfly Network (NYSE:BFLY) has been named one of 2024's Fierce 50 honorees by Fierce Life Sciences and Fierce Healthcare. This recognition highlights Butterfly's advancements in medical imaging through its portable, semiconductor-based ultrasound technology. Key achievements include:
1. The successful launch of the next-generation Butterfly iQ3™
2. Establishment of the Butterfly Garden™ program for ultrasound AI innovation
3. Creation of a chip-licensing program for partners to develop technologies Powered by Butterfly™
CEO Joseph DeVivo emphasized the company's mission to democratize medical imaging by improving access, affordability, and sustainability. The Fierce 50 recognition underscores Butterfly's role in driving digital revolution in the ultrasound industry.
Butterfly Network (NYSE:BFLY) è stata nominata tra i Fierce 50 honorees del 2024 da Fierce Life Sciences e Fierce Healthcare. Questo riconoscimento evidenzia i progressi di Butterfly nel campo dell'imaging medico grazie alla sua tecnologia ultrasonica portatile e basata su semiconduttori. I principali traguardi includono:
1. Il lancio con successo della Butterfly iQ3™ di nuova generazione
2. La creazione del programma Butterfly Garden™ per l'innovazione dell'IA nell'ultrasonografia
3. La realizzazione di un programma di licenza dei chip per i partner per sviluppare tecnologie Powered by Butterfly™
Il CEO Joseph DeVivo ha sottolineato la missione dell'azienda di democratizzare l'imaging medico migliorando l'accessibilità, l'affordabilità e la sostenibilità. Il riconoscimento Fierce 50 evidenzia il ruolo di Butterfly nel guidare la rivoluzione digitale nell'industria degli ultrasuoni.
Butterfly Network (NYSE:BFLY) ha sido nombrada uno de los Fierce 50 honorees de 2024 por Fierce Life Sciences y Fierce Healthcare. Este reconocimiento destaca los avances de Butterfly en la imagenología médica a través de su tecnología de ultrasonido portátil basada en semiconductores. Los logros clave incluyen:
1. El exitoso lanzamiento de la Butterfly iQ3™ de nueva generación
2. Establecimiento del programa Butterfly Garden™ para la innovación de IA en ultrasonido
3. Creación de un programa de licencias de chips para que los socios desarrollen tecnologías Powered by Butterfly™
El CEO Joseph DeVivo enfatizó la misión de la empresa de democratizar la imagenología médica al mejorar el acceso, la asequibilidad y la sostenibilidad. El reconocimiento Fierce 50 subraya el papel de Butterfly en impulsar la revolución digital en la industria del ultrasonido.
Butterfly Network (NYSE:BFLY)는 Fierce Life Sciences와 Fierce Healthcare에 의해 2024년 Fierce 50 honorees 중 하나로 선정되었습니다. 이 인정을 통해 Butterfly가 반도체 기반의 휴대용 초음파 기술을 통해 의학 이미징에서 이룬 발전이 강조됩니다. 주요 성과는 다음과 같습니다:
1. 차세대 Butterfly iQ3™의 성공적인 출시
2. 초음파 AI 혁신을 위한 Butterfly Garden™ 프로그램의 설립
3. 파트너가 Butterfly™로 구동되는 기술을 개발할 수 있는 칩 라이선스 프로그램의 생성
CEO 조셉 드비보는 접근성, 적정성 및 지속 가능성을 개선하여 의료 이미징을 민주화하려는 회사의 사명을 강조했습니다. Fierce 50의 인정은 초음파 산업에서 디지털 혁명을 주도하는 Butterfly의 역할을 강조합니다.
Butterfly Network (NYSE:BFLY) a été désignée comme l'un des Fierce 50 honorees de 2024 par Fierce Life Sciences et Fierce Healthcare. Cette reconnaissance met en avant les avancées de Butterfly dans l'imagerie médicale grâce à sa technologie d'échographie portable basée sur des semi-conducteurs. Les réalisations clés comprennent :
1. Le lancement réussi de la Butterfly iQ3™ de nouvelle génération
2. L'établissement du programme Butterfly Garden™ pour l'innovation en IA en échographie
3. La création d'un programme de licence de puce pour que les partenaires développent des technologies Powered by Butterfly™
Le PDG Joseph DeVivo a souligné la mission de l'entreprise de démocratiser l'imagerie médicale en améliorant l'accès, l'abordabilité et la durabilité. La reconnaissance Fierce 50 souligne le rôle de Butterfly dans la conduite de la révolution numérique dans l'industrie de l'échographie.
Butterfly Network (NYSE:BFLY) wurde von Fierce Life Sciences und Fierce Healthcare als einer der Fierce 50 honorees für 2024 ausgezeichnet. Diese Anerkennung hebt Butterflies Fortschritte in der medizinischen Bildgebung durch seine tragbare, auf Halbleitern basierende Ultraschalltechnologie hervor. Zu den wichtigsten Erfolgen gehören:
1. Der erfolgreiche Start des next-generation Butterfly iQ3™
2. Die Einrichtung des Butterfly Garden™-Programms für Innovationen im Ultraschall-AI-Bereich
3. Die Schaffung eines Chip-Lizenzprogramms für Partner zur Entwicklung von Technologien Powered by Butterfly™
CEO Joseph DeVivo betonte die Mission des Unternehmens, die medizinische Bildgebung zu demokratisieren, indem der Zugang, die Erschwinglichkeit und die Nachhaltigkeit verbessert werden. Die Anerkennung als Fierce 50 hebt die Rolle von Butterfly bei der digitalen Revolution in der Ultraschallbranche hervor.
- Recognition as a 2024 Fierce 50 honoree, highlighting the company's innovation and industry leadership
- Successful launch of the next-generation Butterfly iQ3™ ultrasound device
- Establishment of the Butterfly Garden™ program for AI innovation in ultrasound
- Creation of a chip-licensing program to expand the use of Butterfly's Ultrasound-on-Chip™ technology
- None.
Butterfly Network named a 2024 Fierce 50 Honoree. (Graphic: Business Wire)
Butterfly’s inclusion in the Fierce 50 is a reflection of the exceptional progress the Company has made this year. The successful launch of the next-generation Butterfly iQ3™ has solidified Butterfly’s leadership in revolutionizing the ultrasound industry. The Company has also established itself as a key catalyst for ultrasound artificial intelligence (AI) innovation through its Butterfly Garden™ program, creating an ecosystem for developers to bring the best AI tools to Butterfly’s expansive physician network. Simultaneously, Butterfly has ensured the benefits of its proprietary Ultrasound-on-Chip™ will reach well-beyond its core ultrasound market by creating a chip-licensing program that enables partners to develop novel technologies that are Powered by Butterfly™.
“Being named to the Fierce 50 is a testament to our team’s relentless pursuit of innovation and excellence,” said Joseph DeVivo, President, Chief Executive Officer, and Board Chairman of Butterfly Network. “As a mission-driven company, we are honored to be recognized for our leadership in democratizing medical imaging by advancing access, affordability and sustainability with our chip-based, environmentally-conscious solution. We are proud to be driving a digital revolution for the ultrasound industry at large, and pushing toward a future where practitioners everywhere use digital ultrasound to practice faster, better medicine for patients worldwide.”
“The annual Fierce 50 special report highlights individuals and companies that are driving progress in the pharmaceutical, healthcare and biotechnology industries,” said Ayla Ellison, Editor-in-Chief of Fierce Life Sciences and Healthcare. “These 50 outstanding organizations and people demonstrate excellence in their fields, and their commitment to innovation, equity and improving lives is truly commendable. Congratulations to this year’s honorees.”
The Fierce 50 is a constellation of the most brilliant visionaries and trailblazers, handpicked by the discerning editors of Fierce Biotech, Fierce Pharma and Fierce Healthcare. These individuals and companies are a driving force in healthcare delivery, drug development, research, and more.
To read the Butterfly feature article in the 2024 Fierce 50 report, visit https://www.fiercepharma.com/pharma/butterfly-network. To learn more about Butterfly, visit: https://www.butterflynetwork.com/
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission is to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly created the world's first handheld single-probe, whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore’s Law, to launch its second generation Butterfly iQ+ in 2020, and third generation iQ3 in 2024 – each with increased processing power and performance enhancements. The disruptive technology has been recognized by TIME’s Best Inventions, Fast Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of
About Questex
Questex helps people live better and longer. Questex brings people together in the markets that help people live better: travel, hospitality and wellness; the industries that help people live longer: life science and healthcare; and the technologies that enable and fuel these new experiences. We live in the experience economy – connecting our ecosystem through live events, surrounded by data insights and digital communities. We deliver experience and real results. It happens here.
The Fierce 50 honorees will be celebrated live at an evening gala at the Lighthouse at Pier Sixty One in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240909393991/en/
Questex Media:
Linda Lam
Director of Marketing, Life Sciences and Healthcare
llam@questex.com
Butterfly Media:
Liz Learned
Head of Corporate Communications, Butterfly
media@butterflynetwork.com
Butterfly Investors:
Heather Getz
Chief Financial and Operations Officers, Butterfly
investors@butterflynetwork.com
Source: Butterfly Network, Inc.
FAQ
What is Butterfly Network's stock symbol?
What major recognition did Butterfly Network receive in 2024?
What is the Butterfly iQ3™?
What is the Butterfly Garden™ program?
